Persistent Endothelial activation and inflammation after plasmodium falciparum infection in Malawian children

Journal of Infectious Diseases

Volumn 209, Issue 4, 2014, Pages 610-615

  Moxon, Christopher A ^a,d,e   Chisala, Ngawina V ^a   Wassmer, Samuel C ^f   Taylor, Terrie E ^b,c,g   Seydel, Karl B ^b,c,g   Molyneux, Malcolm E ^d   Faragher, Brian ^d   Kennedy, Neil ^c   Toh, Cheng Hock ^e   Craig, Alister G ^d   Heyderman, Robert S ^a,d  

^a UNIVERSITY OF MALAWI   (Malawi)

^b Blantyre Malaria Project   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^d LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^e UNIVERSITY OF LIVERPOOL   (United Kingdom)

^f NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

cardiovascular disease; endothelial activation; endothelial dysfunction; inflammation; pathogen burden; pediatric; Plasmodium falciparum; stroke

Indexed keywords

CARDIOVASCULAR DISEASE; ENDOTHELIAL ACTIVATION; ENDOTHELIAL DYSFUNCTION; INFLAMMATION; PATHOGEN BURDEN; PEDIATRIC; PLASMODIUM FALCIPARUM; STROKE;

ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; ENDOTHELIUM; FEMALE; FEVER; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; MALARIA, CEREBRAL; MALARIA, FALCIPARUM; MALAWI; MALE; VESICULAR TRANSPORT PROTEINS;

EID: 84893269487     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit419     Document Type: Conference Paper

References (19)

1. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005; 434:214-7.
2. Snow RW, Marsh K. The consequences of reducing transmission of Plasmodium falciparum in Africa. Adv Parasitol 2002; 52:235-64.
3. Murray CJ, Rosenfeld LC, Lim SS, et al. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 2012; 379:413-31.
4. Bhattarai A, Ali AS, Kachur SP, et al. Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. PLoS Med 2007; 4:e309.
5. Scott JA, Berkley JA, Mwangi I, et al. Relation between falciparum malaria and bacteraemia in Kenyan children: a population-based, casecontrol study and a longitudinal study. Lancet 2011; 378:1316-23.
6. World Health Organization. WHO Expert Committee on Malaria. World Health Organ Tech Rep Ser 2000; 892:i-v, 1-74.
7. Taylor TE, Fu WJ, Carr RA, et al. Differentiating the pathologies of cerebral malaria by postmortemparasite counts. NatMed 2004; 10:143-5.
8. Aird WC. Endothelial cell heterogeneity. Cold Spring Harb Perspect Med 2012; 2:a006429.
9. Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003; 170:191-203.
10. Moxon CA, Grau GE, Craig AG. Malaria: modification of the red blood cell and consequences in the human host. Br J Haematol 2011; 154:670-9.
11. Moxon CA, Wassmer SC, Milner DA Jr, et al. Loss of endothelial protein C receptors links coagulation and inflammation to parasite sequestration in cerebral malaria in African children. Blood 2013; 122:842-51.
12. Ochola LB, Siddondo BR, Ocholla H, et al. Specific receptor usage in Plasmodium falciparum cytoadherence is associated with disease outcome. PLoS One 2011; 6:e14741.
13. Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 1993; 91:1351-7.
14. Fiedler U, Scharpfenecker M, Koidl S, et al. The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cellWeibel-Palade bodies. Blood 2004; 103:4150-6.
15. Zhu J, Nieto FJ, Horne BD, Anderson JL, Muhlestein JB, Epstein SE. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 2001; 103:45-51.
16. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359:2195-207.
17. Dalal S, Beunza JJ, Volmink J, et al. Non-communicable diseases in sub-Saharan Africa: what we know now. Int J Epidemiol 2011; 40: 885-901.
18. Yeo TW, Lampah DA, Gitawati R, et al. Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria. Proc Natl Acad Sci USA 2008; 105:17097-102.
19. Reis PA, Estato V, da Silva TI, et al. Statins decrease neuroinflammation and prevent cognitive impairment after cerebral malaria. PLoS Pathog 2012; 8:e1003099.